speb/financial-data huggingface dataset:
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 16511000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 14459000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -483000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -210000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -3633000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 29636270000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 29636270000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -933000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 2052000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 33020720000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 33020720000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 10710000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 10710000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 589690000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 589690000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2940130000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2940130000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1008600000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1008600000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 725950000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 725950000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 4174000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1503000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Normalized Income: 1188111782.48
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 391200000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 713000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Operating Income: 2322000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Operating Income: 779000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 33456000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 13494000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 78572885.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 78572885.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 74320000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 74320000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 66630000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 66630000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 274620000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 274620000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 1311340000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1311340000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 248210000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 248210000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 429000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 63140000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 63140000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 57280000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 57280000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 334000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 204000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 8175000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 3329000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 2512040000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 2512040000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Other Properties: 22061940000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 22061940000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 1012140000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1012140000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 3368770000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 3368770000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Other Special Charges: 1036000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Other Special Charges: 616000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Payables: 17442300000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 17442300000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 222350000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 222350000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 5181520000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 5181520000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Pretax Income: 993000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 106000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 316000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: -8976000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -15501000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -946000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 5831550000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 5831550000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 17737000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 6924000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 1662000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 571000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 140290000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 140290000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -1429000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 3982330000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 3982330000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: 1036250000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 9753650000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 13172000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 13000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 127850000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 1107090000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 78572885.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 78572885.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Special Income Charges: -1036000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: -616000000.00
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 34400500000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 34400500000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 33020720000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 33020720000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -406888217.52
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -184800000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Tax Provision: 390000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 102000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.39
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
SUDARSCHEM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -825000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 97307110000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 97307110000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 50719390000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 50719390000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 23775210000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 23775210000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 40382990000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 40382990000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Total Expenses: 31134000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 12715000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 56924120000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 56924120000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 35636040000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 35636040000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 27778580000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 27778580000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 81800000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 874150000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 874150000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -1036000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -616000000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -1036000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -616000000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Work In Process: 3941170000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 3941170000.00
SUDARSCHEM.NS balance_sheet (annual, 2025-03-31) — Working Capital: 32525530000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 32525530000.00
SUDARSCHEM.NS income_statement (annual, 2025-03-31) — Write Off: 101160000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 5326000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 25069000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 78666667.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 6.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 12228000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 990000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 990000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 78666667.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 6.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 472000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — EBIT: 1263000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — EBITDA: 2253000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 12841000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 441000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 441000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -78000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income: 472000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 472000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 550000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 472000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 472000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 550000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -441000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -441000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2581000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 691464720.19
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Income: 7515000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 25069000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -6110000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 822000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 12228000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 990000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 328000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: -328000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -108535279.81
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 272000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.33
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 17554000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: -328000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -328000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 5129000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 23874000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 14539000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 12070000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 467000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 78000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.50
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 3223000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 157000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 7721000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 13143000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 157000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 35202000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 1594000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 11908000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 59882000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 652000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 3858000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 4510000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 27371000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 858000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 972000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 972000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 78000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.50
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 117000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — EBIT: 731000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — EBITDA: 1703000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Financial Assets: 0.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 68000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1411000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 30756000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 11966000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 7000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 436000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 436000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 28085000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 57259000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 467000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 2107000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 2571000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 18199000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 20770000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 2107000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 6749000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 3996000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Minority Interests: -76000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 14336000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income: 117000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 117000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 193000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 117000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 117000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 193000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -436000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -436000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 30756000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 33791000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 1478000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 3320000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1703000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 117000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Operating Income: 6837000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 23874000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 78596469.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 6575000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1751000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 35045000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1343000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1038000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 68000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -6418100000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 29162000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 5422000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Payables: 15801000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 295000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 11908000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 972000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 78596469.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 35202000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 33791000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 102000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.35
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 97545000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 53401000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 25280000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 39198000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 17037000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 58347000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 37663000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 30976000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1262000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
SUDARSCHEM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
SUDARSCHEM.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 32511000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 10685000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 21030000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 78435374.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: -14.70
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 10815000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1006000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 1006000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 78435374.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: -14.70
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1153000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — EBIT: -864000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — EBITDA: 142000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 10215000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 364000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 364000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 7000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income: -1153000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1153000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1160000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1153000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1153000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -1160000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -364000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -364000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 596000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -724140065.15
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Income: -470000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 21030000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 142000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 5726000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: 454000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -1228000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 10815000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1006000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -454000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -25140065.15
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: -68000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.06
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 21500000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -454000000.00
SUDARSCHEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -454000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 45560000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 11644000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 97872000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 27899000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 15340000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 15340000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 16790000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 16790000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 544000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 544000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 79642857.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 78700000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Basic EPS: 2.80
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 10.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 11043000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -2704000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 3542000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3542000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 157000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 157000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 9329000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 9329000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 15556000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 15556000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -356000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 3603000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 3492000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -3848000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Change In Payable: -3530000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -288000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -690000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -1713000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 157000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 157000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -356000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 34502000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 34502000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 18000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 1195000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1195000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 49718000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 14767000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 59644000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 59644000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 787000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 787000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 4711000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 4711000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 5498000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5498000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 28975000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 28975000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 921000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 921000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Depreciation: 3472000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 3472000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 3472000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 504000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 3472000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 504000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 79642857.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 78700000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Diluted EPS: 2.80
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 10.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 223000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 787000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 399000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — EBIT: 3215000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — EBIT: 2085000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — EBITDA: 6687000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — EBITDA: 2589000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 0.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 9329000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Financial Assets: 0.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets: 0.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -6802000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 736000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -6000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 40000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Goodwill: 68000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 68000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 1509000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1509000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 29806000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 29806000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Gross Profit: 48154000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 13132000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 9000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 9000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Interest Expense: 1649000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 408000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1649000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 408000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -1241000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 183000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Inventory: 24436000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 24436000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 55692000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 55692000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 1649000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 544000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 544000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Investments In Other Ventures Under Equity Method: 2319000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 2319000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 18000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 2755000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 2755000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 16479000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 16479000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 19234000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 19234000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 0.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -3160000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 2319000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 2319000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 7401000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 7401000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 4038000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 4038000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Minority Interests: -185000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -38000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 0.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 18000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Net Debt: 11861000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 11861000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 99000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Net Income: 223000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income: 787000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 223000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 787000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 408000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 825000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 223000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 787000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 223000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 787000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1566000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 408000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 825000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -1649000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -408000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 127000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -2424000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -3160000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1649000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -408000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -2255000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 3615000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 29806000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 29806000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -2675000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 736000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 32993000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 32993000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 1706000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1706000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2951000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2951000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 8130000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 2638000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Normalized Income: 1088800000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 816400000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 3440000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Operating Income: 2594000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Operating Income: 1488000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 97872000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 27899000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 78611936.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 78611936.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: -1000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 2828000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2828000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 1660000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1660000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 34345000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 34345000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 1441000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1441000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 1300000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 1228000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1228000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 60000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 60000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 792000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 104000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 26571000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 7129000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 28611000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 28611000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 25000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 25000000.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 6227000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 6227000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Other Special Charges: 297000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Other Special Charges: -157000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
SUDARSCHEM.NS balance_sheet (annual, 2026-03-31) — Payables: 16524000000.00
SUDARSCHEM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 16524000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Pretax Income: 1566000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 1677000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -17000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -11436000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -2704000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 49718000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 14767000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 3472000000.00
SUDARSCHEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 504000000.00
SUDARSCHEM.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -3160000000.00
SUDARSCHEM.NS income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: 1146000000.00